-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Fate Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
- Fate Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 118M shares, a 19.5% increase year-over-year.
- Fate Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 98.4M shares, a 1.64% increase from 2022.
- Fate Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 96.8M shares, a 2.19% increase from 2021.
- Fate Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 94.7M shares, a 15% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)